Ventyx Biosciences, Inc. Share Price
VTYXVentyx Biosciences, Inc. Stock Performance
Open $13.91 | Prev. Close $13.94 | Circuit Range N/A |
Day Range $13.91 - $13.96 | Year Range $0.78 - $15.31 | Volume 27,970 |
Average Traded $13.94 |
Ventyx Biosciences, Inc. Share Price Chart
About Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for Crohn's disease. It is also developing Tamuzimod, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor that is in Phase 2a trial for patients with early Parkinson's disease and is in Phase 2 trial for patients with obesity and additional risk factors for cardiovascular disease. Ventyx Biosciences, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Ventyx Biosciences, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Feb-26 | $13.96 | $13.90 | -0.36% |
03-Feb-26 | $13.95 | $13.96 | -0.04% |
02-Feb-26 | $13.95 | $13.96 | +0.14% |
30-Jan-26 | $13.96 | $13.94 | -0.11% |
29-Jan-26 | $13.95 | $13.96 | -0.11% |
28-Jan-26 | $13.99 | $13.97 | -0.07% |
27-Jan-26 | $14.00 | $13.98 | +0.00% |
FAQs on Ventyx Biosciences, Inc. Share Price
Can I buy Ventyx Biosciences, Inc. shares in India?
What is the share price of Ventyx Biosciences, Inc.?
What is the 5 year returns of Ventyx Biosciences, Inc.?
What are the high & low stock price of Ventyx Biosciences, Inc. today?
What is the 52-week high and low of Ventyx Biosciences, Inc. stock?